Published: Guidance, quality standards and advice
Showing 1671 to 1680 of 2520
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Adalimumab for treating moderate to severe hidradenitis suppurativa | TA392 | ||
| Breast cancer | QS12 | ||
| S-Cath System for suprapubic catheterisation | MIB68 | ||
| Complicated urinary tract infections: ceftolozane/tazobactam | ESNM74 | ||
| Complicated intra-abdominal infections: ceftolozane/tazobactam | ESNM75 | ||
| Endovenous mechanochemical ablation for varicose veins | IPG557 | ||
| Haematological cancers: improving outcomes | NG47 | ||
| Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes | TA390 | ||
| Reversal of the anticoagulant effect of dabigatran: idarucizumab | ESNM73 | ||
| CareLink network service for remote monitoring of people with cardiac devices | MIB64 |